Dysplastic Nevi Grading & Atypia

Dysplastic nevi, also known as atypical moles, are common skin lesions that can resemble melanoma. Their grading—mild, moderate, or severe—helps determine melanoma risk and guides management. This article covers the spectrum from mild dysplastic nevi to severe dysplastic nevi, explaining the histologic features of atypia and clinical implications.

These atypical moles are acquired lesions with architectural and cytologic atypia. They are typically larger than common moles (>5 mm), have irregular borders, and variable color. The term “dysplastic nevus” encompasses a range from dysplasia with mild atypia to that with severe atypia. Grading is based on histologic criteria and is crucial for risk stratification.

Understanding Dysplastic Nevi

These moles are considered precursors to melanoma, though most remain benign. They occur in both sporadic and familial settings. Individuals with multiple such moles have a higher lifetime risk of melanoma. The grading system helps identify low grade dysplastic nevi (mild) versus high grade dysplastic nevi (moderate to severe). This distinction influences follow-up intervals and the need for excision.

Histologically, atypical nevi show lentiginous proliferation of melanocytes with bridging of rete ridges, fibroplasia, and concentric eosinophilic fibrosis. Cytologic atypia refers to nuclear enlargement, hyperchromasia, and irregular nuclear contours. The degree of cytologic atypia is graded as mild, moderate, or severe.

The Grading System: Mild, Moderate, and Severe

Grading of these lesions is based on the severity of cytologic and architectural atypia. It is a subjective assessment, but standardized criteria exist. Below is a breakdown of each grade:

Mild dysplastic nevi: Mild cytologic atypia (slight nuclear enlargement, minimal hyperchromasia) and architectural changes (focal bridging, mild fibroplasia). These are considered low grade dysplastic nevi and have very low malignant potential.
Moderate dysplastic nevi: Moderate cytologic atypia (more prominent nuclear enlargement, visible nucleoli) and architectural changes (more extensive bridging, lamellar fibroplasia). These are intermediate risk and often require wider excision if margins are positive.
Severe dysplastic nevi: Severe cytologic atypia (marked nuclear enlargement, hyperchromasia, irregular nuclear contours) with pronounced architectural disarray (confluent melanocytes, pageroid spread?). These are high grade dysplastic nevi and carry the highest risk of progression to melanoma.

It is important to note that the term “dysplastic nevus with mild atypia” is used synonymously with mild dysplastic nevi, and similarly for moderate and severe. Some pathologists prefer the term “atypical melanocytic nevus” instead.

Key Point: The distinction between low grade (mild) and high grade (moderate to severe) dysplastic nevi is clinically important. Low grade lesions can often be managed with observation, while high grade lesions typically require re-excision to clear margins and rule out melanoma.

Importance of Accurate Grading

Accurate grading of these atypical moles is essential for risk assessment and management. Studies show that high grade dysplastic nevi have a higher risk of harboring melanoma or progressing to melanoma. Therefore, a diagnosis of dysplastic nevus with severe atypia often prompts re-excision with a 5 mm margin, whereas dysplastic nevus with mild atypia may be followed clinically if margins are negative.

In addition, the presence of multiple atypical moles, especially if any are high grade, increases the need for regular skin surveillance. Patients with familial atypical mole syndrome (also known as dysplastic nevus syndrome) are at very high risk and require total body photography and frequent dermatologic exams.

Warning: Any changing mole or one that shows features of severe atypia should be biopsied. Do not ignore lesions that exhibit the ABCDEs of melanoma (Asymmetry, Border irregularity, Color variation, Diameter >6 mm, Evolution).

Management and Follow-Up

Management of these moles depends on the grade and margin status. General guidelines include:

For mild dysplastic nevi with clear margins: no further treatment; routine skin checks.
For moderate dysplastic nevi with positive margins: re-excision recommended.
For severe dysplastic nevi: re-excision regardless of margin status to ensure complete removal and rule out melanoma.
Patients with multiple atypical moles should have regular dermatologic examinations every 6–12 months.

In summary, understanding the grading of dysplastic nevi from mild to severe is crucial for dermatologists and patients. While low grade dysplastic nevi are generally benign, high grade dysplastic nevi warrant aggressive management to prevent melanoma. Always consult a dermatologist for personalized advice.